Growth & Performance Peptides
Growth hormone secretagogues for research on the hypothalamic-pituitary-IGF-1 axis. Selective GHRH mimetics such as Sermorelin and Tesamorelin, GHRP agonists such as Ipamorelin and the popular CJC-1295 (No-DAC)/Ipamorelin combination, alongside IGF-1 LR3 for IGF-1 receptor research and Melanotan-2 for melanocortin studies. All compounds are used in preclinical models for endocrine signalling pathways, body-composition endpoints and regeneration markers. Supplied with a batch-specific Janoshik third-party certificate of analysis.
All products
Related research
July 22, 2026
PT-141 (Bremelanotide): What the Phase 3 Trials Actually Showed
PT-141 is one of the few research peptides that completed randomised phase 3 trials. What those trials found, what an independent re-analysis disputes, and what the safety record really says.
Read more →
July 22, 2026
Buy PT-141 (Bremelanotide): What to Check Before You Order
PT-141 for research use: what the evidence base really is, what a batch certificate has to show, how it differs from Melanotan-2, and the legal position in the EU.
Read more →
July 20, 2026
GH Peptide Side Effects in the Research: Ipamorelin, CJC-1295, Sermorelin, Tesamorelin
What the published trials actually report on growth-hormone peptide tolerability: injection-site reactions, IGF-1 elevation, fluid balance and glucose, plus the honest limits of the human evidence.
Read more →








